CohnJNJohnsonGRShabetiR: Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation1993;87: VI–16.
2.
FallavollitaJAJacobSYoungRF: Regional alterations in SR Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol1999;277:H1418–28.
3.
Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology: Remme WJ, Swedberg K (Co-chairmen). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J2001;22:1527–1560.
4.
MockMBRingqvistIFisherLD: Survival of medically treated patients in the Coronary Artery Surgery Study (CASS). Circulation1982;66:562–568.
5.
BaxJJPoldermansDElhendyA: Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol2001;26:141–188.
6.
SchinkelAFBaxJJSozziFBBoersmaEValkemaRElhendyARoelandtJRPoldermansD: Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Heart. 2002;88(2):125–130.
7.
von DahlJAltehoeferCSheehanFH: Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol1996;28:948–958.
8.
VanoverscheldeJLDepreCGerberBL: Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol2000;85:1432–1439.
9.
AuerbachMASchroderHHohC: Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation1999;99:2921–2926.
10.
HaasFHaehnelCJPickerW: Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol1997;30:1693–1700.
11.
BeanlandsRSDeKempRASmithS: F-18 fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function. Am J Cardiol1997;79:1092–1095.
12.
UnderwoodSRBaxJJvon DahlJHeneinMYKnuutiJvan RossumACSchwarzERVanoverscheldeJLvan der WallEEWijnsW; Study Group of the European Society of Cardiology: Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J. 2004;25(10):81–836.
13.
TillischJBrunkenRMarshallR: Reversibility of cardiac wallmotion abnormalities predicted by positron emission tomography. N Engl J Med1986;314:884–888.
14.
KnuutiMJSarasteMNuutilaPHarkonenRWegeliusUHaapanenABergmanJHaaparantaMSavunenTVoipio-PulkkiLM: Myocardial viability: Fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J. 1994 Apr; 127(4 Pt 1:785–796.
15.
VanoverscheldeJ-LJDeHondtA-MMarwickT: Head-to-head comparison of exercise-redistribution-reinjection thallium single photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol1996;28:432–442.
16.
GunningMGAnagnostopoulosCKnightCJ: Comparison of Tl-201, technetium-99m tetrofosmin and dobutamine magnetic resonance imaging in identifying hibernating myocardium. Circulation1998;98:1869–1874.
17.
UdelsonJEColemanPSMetherallJ: Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation1994;89:2552–2561.
18.
SciagraRBisiGSantoroGM: Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labelled sestamibi single photon emission computed tomography. J Nucl Cardiol1996;3:221–230.
19.
BurtRWPerkinsOWOppenheimBE: Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med1995;36:176–179.
20.
PrevitaliMPoliALanzariniL: Dobutamine stress echocardiography for assessment of myocardial viability and ischaemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol1993;72:124G–30G.
21.
LauermaKNiemiPHanninenHJanatuinenTVoipio-PulkkiLMKnuutiJToivonenLMakelaTMakijarviMAAronenHJ: Multimodality MR imaging assessment of myocardial viability: Combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology2000;217(3):729–736.
22.
BaerFMTheissenPCrnacJ: Head to head comparison of dobutamine-transoesophageal echocardiography and dobutaminemagnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J2000;21:981–991.
23.
HigginsCB: Prediction of myocardial viability by MRI. Circulation1999;99:727–729.
24.
GeskinGKramerCMRogersWJ: Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation1998;98:217–223.
25.
NagelELehmkuhlHBBockschW: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of highdose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation1999;99:763–770.
26.
HundleyWGHamiltonCAThomasMS: Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation1999;100:1697–702.
27.
WagnerAMahrholdtHRegenfusM: Contrast-enhanced MIR and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet2003;361:374–379.
28.
ForderJRPohostGM: Cardiovascular nuclear magnetic resonance: Basic and clinical applications. J Clin Invest2003;111:1630–1639.
29.
MahnkenAHKoosRKatohM: Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol2005;45:2042–2047.
30.
KitsiouANSrinivasanGQuyyumiAASummersRMBacharachSLDilsizianV: Stress-induced reversible and mild-to-moderate irreversible thallium defects: Are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation1998;98(6):501–508.
31.
IsbellDCKramerCM: Magnetic resonance for the assessment of myocardial viability. Curr Opin Cardiol2006;21(5):469–472.
32.
KimRJWuERafaelAChenELParkerMASimonettiOKlockeFJBonowROJuddRM: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med2000;343(20):1445–1453.
33.
KaandorpTALambHJvan der WallEEDe RoosABaxJJ: Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart2005;91(10):1359–1365.
34.
BaxJJPoldermansDElhendyA: Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol1999;34:163–169.
35.
EitzmanDAl-AouarZRKanterHL: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol1992;20:559–565.
36.
Di CarliMDavidsonMLittleR: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol1994;73:527–353.
37.
Di CarliMFAsgarzadieFSchelbertHRBrunkenRCLaksHPhelpsMEMaddahiJ: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation1995;92(12):3436–344.
38.
AllmanKCShawLJHachamovitchRUdelsonJE: Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol2002;39(7):1151–1158.
